Anti-Inflammatory Peptides From Insect, Spider, and Scorpion Venoms: A Systematic Review

A systematic review of 171 studies found that peptides from arthropod venoms — including those from bees, scorpions, spiders, and crabs — have significant anti-inflammatory activity, primarily by reducing pro-inflammatory cytokines.

Dos Santos, Ariane Teixeira et al.·The journal of venomous animals and toxins including tropical diseases·2021·n/a (review)systematic review
RPEP-05351Systematic reviewn/a (review)2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
systematic review
Evidence
n/a (review)
Sample
N=171 studies reviewed
Participants
Published studies on anti-inflammatory peptides from insects, crustaceans, arachnids, and centipedes

What This Study Found

From 171 reviewed studies, arthropod-derived peptides from 9 animal groups demonstrated anti-inflammatory activity, primarily by decreasing pro-inflammatory cytokines in vitro and in vivo, with some also exhibiting anticancer properties.

Key Numbers

171 studies; 9 peptide families; sources: ants, bees, wasps, shrimp, crabs, scorpions, spiders, ticks, centipedes

How They Did This

Systematic review following PRISMA guidelines. PubMed, Scopus, Web of Science, and Google Scholar searched with no publication date limit. 171 studies met inclusion/exclusion criteria for data extraction.

Why This Research Matters

Current anti-inflammatory drugs often have significant side effects. Arthropod venom peptides offer a diverse library of natural anti-inflammatory molecules that could lead to new, more targeted treatments with fewer adverse effects.

The Bigger Picture

Venom-derived peptides are an expanding frontier in drug discovery. Nature has optimized these molecules over millions of years of evolution, creating potent and selective bioactive compounds. This review highlights their under-explored potential for treating inflammatory and neoplastic diseases.

What This Study Doesn't Tell Us

Systematic review with no new experimental data. Most included studies used in vitro or animal models. Clinical translation of venom peptides faces significant challenges including toxicity, stability, and manufacturing. Human safety data is largely absent.

Questions This Raises

  • ?Which arthropod venom peptides are closest to clinical development as anti-inflammatory drugs?
  • ?Can synthetic versions of these peptides retain anti-inflammatory activity while eliminating toxicity?
  • ?Could venom peptides with dual anti-inflammatory and anticancer properties address inflammatory cancers?

Trust & Context

Key Stat:
171 studies, 9 animal groups Anti-inflammatory peptides have been documented across virtually all major arthropod groups, from insects to arachnids to crustaceans
Evidence Grade:
Not applicable (systematic review). Synthesizes primarily preclinical evidence from in vitro and animal studies.
Study Age:
Published in 2021. Venom peptide research continues to expand with improved synthetic and recombinant production methods.
Original Title:
Anti-inflammatory activities of arthropod peptides: a systematic review.
Published In:
The journal of venomous animals and toxins including tropical diseases, 27, e20200152 (2021)
Database ID:
RPEP-05351

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

How can venomous animal peptides be anti-inflammatory?

Venom peptides evolved to modulate the victim's immune and nervous systems. Some components suppress inflammation — a property that, when isolated and refined, could be repurposed as targeted anti-inflammatory drugs without the full venom's toxic effects.

Are any venom-based drugs already in use?

Yes — examples include ziconotide (from cone snail venom) for pain and exenatide (from Gila monster saliva) for diabetes. The anti-inflammatory venom peptides reviewed here are earlier in development but follow the same drug-discovery approach.

Read More on RethinkPeptides

Cite This Study

RPEP-05351·https://rethinkpeptides.com/research/RPEP-05351

APA

Dos Santos, Ariane Teixeira; Cruz, Gabriela Silva; Baptista, Gandhi Rádis. (2021). Anti-inflammatory activities of arthropod peptides: a systematic review.. The journal of venomous animals and toxins including tropical diseases, 27, e20200152. https://doi.org/10.1590/1678-9199-JVATITD-2020-0152

MLA

Dos Santos, Ariane Teixeira, et al. "Anti-inflammatory activities of arthropod peptides: a systematic review.." The journal of venomous animals and toxins including tropical diseases, 2021. https://doi.org/10.1590/1678-9199-JVATITD-2020-0152

RethinkPeptides

RethinkPeptides Research Database. "Anti-inflammatory activities of arthropod peptides: a system..." RPEP-05351. Retrieved from https://rethinkpeptides.com/research/dos-2021-antiinflammatory-activities-of-arthropod

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.